Chimeric Antigen Receptor Top Open Access Journals
Chimeric antigen receptors are receptor proteins that have been engineered to give T
cells the new amplitude to target a specific protein. The receptors are chimeric because they syndicate both antigen-binding and T-cell activating functions into a single receptor.
Scientists harvest T
cells from people, genetically change them, then infuse the causing CAR-T
cells into patients to strike their tumors.CAR-T
cells can be either derived from T
cells in a patient's own blood (autologous) or extract from the T
cells of alternative healthy donor (allogeneic). Once isolated from a person, these T
cells are genetically engineered to express a specific CAR, which programs them to objective an antigen that is current on the surface of tumors.CAR-T cell therapy uses T
cells engineered with CARs for
cancer therapy. The premise of CAR-T
immunotherapy is to transform T
cells to recognize
cancer cells in order to more effectively target and destroy them.
A kind of treatment during which a patient's T
cells (a type of system cell) square measure modified within the laboratory in order that they can attack
cancer cells. T
cells square measure taken from a patient’s blood. Then the factor for a special receptor that binds to a particular macromolecule on the patient’s
cancer cells is superimposed to the T
cells within the laboratory. The special receptor is termed a mythical creature substance receptor (CAR). massive numbers of the automobile T
cells square measure grownup within the laboratory and given to the patient by infusion. mythical creature substance receptor T-cell medical care is employed to treat sure blood cancers, and it's being studied within the treatment of alternative kinds of cancer. conjointly known as automobile T-cell medical care.
High Impact List of Articles
-
2 cases of non-surgical treatment of stent loss during percutaneous coronary intervention
Mohamed Aymen Ben Abdessalem*, Oussama Ben Rejeb, Imen Bouhlel, Abdallah Mahdhaoui, Samia Ernez and Gouider Jeridi Centre Hospitalier Universitaire Farhat Hached de Sousse sousse, sousse Tunisia
Case Report: Interventional Cardiology
-
2 cases of non-surgical treatment of stent loss during percutaneous coronary intervention
Mohamed Aymen Ben Abdessalem*, Oussama Ben Rejeb, Imen Bouhlel, Abdallah Mahdhaoui, Samia Ernez and Gouider Jeridi Centre Hospitalier Universitaire Farhat Hached de Sousse sousse, sousse Tunisia
Case Report: Interventional Cardiology
-
Does the type of treatment affect who makes the decision? Secondary data analysis of patients undergoing angioplasty vs. medical treatment for high cholesterol levels
Ana Tereza Azeredo Bastos Brito and Gustavo Carvalho
Research Article: Interventional Cardiology
-
Does the type of treatment affect who makes the decision? Secondary data analysis of patients undergoing angioplasty vs. medical treatment for high cholesterol levels
Ana Tereza Azeredo Bastos Brito and Gustavo Carvalho
Research Article: Interventional Cardiology
-
Significance of congenital coronary artery fistulas
Umut Kocabas
Short Communication: Interventional Cardiology
-
Significance of congenital coronary artery fistulas
Umut Kocabas
Short Communication: Interventional Cardiology
-
Obstructive sleep apnea, coronary artery disease and continuous positive airway pressure therapy
T Hein, G Loo & C-H Lee
Review Article: Interventional Cardiology
-
Obstructive sleep apnea, coronary artery disease and continuous positive airway pressure therapy
T Hein, G Loo & C-H Lee
Review Article: Interventional Cardiology
-
Highlights from the latest articles in interventional cardiology-1 (2012)
P Das
Research Highlights: Interventional Cardiology
-
Highlights from the latest articles in interventional cardiology-1 (2012)
P Das
Research Highlights: Interventional Cardiology
Relevant Topics in Clinical